Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SS Pharm. licenses AChE inhibitor to Arena

Feb. 13, 1998

Roche discloses new 5-HT2B antagonists

Feb. 13, 1998

Antipsychotic drugs in development at Janssen

Feb. 13, 1998

DuPont Merck claims new CRF antagonists

Feb. 13, 1998

Neurocrine Biosciences and Rigel collaborate on gliosis inhibitors

Feb. 12, 1998

U.S. clearance for naratriptan

Feb. 12, 1998

Potential new antimigraine agents in development at Allelix

Feb. 12, 1998

Warning issued for Duract related to potential hepatotoxicity

Feb. 11, 1998

Wyeth-Ayerst describes synthesis and pharmacological profile of new agent for stroke

Feb. 11, 1998

Solvay and Elan to codevelop new formulation of fluvoxamine

Feb. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...